Atara Biotherapeutics Inc (ATRA)
0.7408
+0.05
(+7.36%)
USD |
NASDAQ |
May 01, 13:47
Atara Biotherapeutics Shareholders Equity (Quarterly): -99.23M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -99.23M |
| September 30, 2023 | -50.84M |
| June 30, 2023 | 7.454M |
| March 31, 2023 | 64.96M |
| December 31, 2022 | 126.64M |
| September 30, 2022 | 187.11M |
| June 30, 2022 | 257.48M |
| March 31, 2022 | 224.32M |
| December 31, 2021 | 279.61M |
| September 30, 2021 | 310.14M |
| June 30, 2021 | 331.54M |
| March 31, 2021 | 399.04M |
| December 31, 2020 | 462.34M |
| September 30, 2020 | 353.94M |
| June 30, 2020 | 381.12M |
| March 31, 2020 | 252.82M |
| December 31, 2019 | 290.78M |
| September 30, 2019 | 318.44M |
| June 30, 2019 | 232.28M |
| March 31, 2019 | 283.93M |
| December 31, 2018 | 338.86M |
| Date | Value |
|---|---|
| September 30, 2018 | 403.05M |
| June 30, 2018 | 452.50M |
| March 31, 2018 | 439.18M |
| December 31, 2017 | 177.86M |
| September 30, 2017 | 205.96M |
| June 30, 2017 | 221.14M |
| March 31, 2017 | 233.13M |
| December 31, 2016 | 253.74M |
| September 30, 2016 | 270.20M |
| June 30, 2016 | 290.24M |
| March 31, 2016 | 303.83M |
| December 31, 2015 | 315.10M |
| September 30, 2015 | 333.75M |
| June 30, 2015 | 149.26M |
| March 31, 2015 | 166.09M |
| December 31, 2014 | 103.18M |
| September 30, 2014 | -23.03M |
| June 30, 2014 | 56.22M |
| March 31, 2014 | -14.70M |
| December 31, 2013 | -11.02M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-99.23M
Minimum
Dec 2023
462.34M
Maximum
Dec 2020
227.89M
Average
257.48M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 39.70M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.50M |
| Total Liabilities (Quarterly) | 264.74M |
| Current Ratio | 0.7162 |